UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 5, 2012

Accession Number:	0001104659-12-041334
Submission Type:	POS AM
CIK: 0001023024 Company Name: BIOSANTE PHARMACEUTICALS INC File Number: 333-136852